124 related articles for article (PubMed ID: 212287)
1. Lipoprotein lipase activator deficiency in very low density lipoproteins in rat nephrotic syndrome.
Kashyap ML; de Mendoza SG; Campbell M; Chen CY; Lutmer RF; Glueck CJ
Experientia; 1978 Aug; 34(8):1044-5. PubMed ID: 212287
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein CII and lipoprotein lipase in human nephrotic syndrome.
Kashyap ML; Srivastava LS; Hynd BA; Brady D; Perisutti G; Glueck CJ; Gartside PS
Atherosclerosis; 1980 Jan; 35(1):29-40. PubMed ID: 7370086
[No Abstract] [Full Text] [Related]
3. Catabolic defect of triglyceride is associated with abnormal very-low-density lipoprotein in experimental nephrosis.
Furukawa S; Hirano T; Mamo JC; Nagano S; Takahashi T
Metabolism; 1990 Jan; 39(1):101-7. PubMed ID: 2294370
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein C-II and lipoprotein lipase activity.
Catapano AL
Ric Clin Lab; 1982; 12(1):35-40. PubMed ID: 7046021
[No Abstract] [Full Text] [Related]
5. Redistribution of apolipoproteins C removed from human very low density lipoprotein during in vitro lipolysis by lipoprotein lipase.
Glangeaud-Freudenthal MC; Burdin J; Ayrault-Jarrier M; Polonovski J
Biochimie; 1981 Jun; 63(6):485-94. PubMed ID: 7260173
[TBL] [Abstract][Full Text] [Related]
6. Ascites fluid lipoproteins in experimental nephrotic syndrome.
Garber DW; Marsh JB
Biochim Biophys Acta; 1988 Apr; 959(3):253-61. PubMed ID: 3355849
[TBL] [Abstract][Full Text] [Related]
7. Isolation and characterization of lipoprotein lipase activators from bovine blood serum.
Sundheim G; Zimmer TL; Astrup HN
J Dairy Sci; 1983 Mar; 66(3):407-14. PubMed ID: 6841745
[TBL] [Abstract][Full Text] [Related]
8. Hypoalbuminemia and proteinuria contribute separately to reduced lipoprotein catabolism in the nephrotic syndrome.
Shearer GC; Stevenson FT; Atkinson DN; Jones H; Staprans I; Kaysen GA
Kidney Int; 2001 Jan; 59(1):179-89. PubMed ID: 11135070
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein lipase: mechanism of action and role in lipoprotein metabolism.
Quinn D; Shirai K; Jackson RL
Prog Lipid Res; 1983; 22(1):35-78. PubMed ID: 6346343
[No Abstract] [Full Text] [Related]
10. High density lipoproteinuria in nephrotic syndrome.
de Mendoza SG; Kashyap ML; Chen CY; Lutmer RF
Metabolism; 1976 Oct; 25(10):1143-9. PubMed ID: 184367
[TBL] [Abstract][Full Text] [Related]
11. Experimental nephrotic syndrome: removal and tissue distribution of chylomicrons and very-low-density lipoproteins of normal and nephrotic origin.
Levy E; Ziv E; Bar-On H; Shafrir E
Biochim Biophys Acta; 1990 Apr; 1043(3):259-66. PubMed ID: 2322571
[TBL] [Abstract][Full Text] [Related]
12. Further observations on the activation and inhibition of lipoprotein lipase by apolipoproteins.
Krauss RM; Herbert PN; Levy RI; Fredrickson DS
Circ Res; 1973 Oct; 33(4):403-11. PubMed ID: 4355035
[No Abstract] [Full Text] [Related]
13. Studies on the degradation of human very low density lipoproteins by human milk lipoprotein lipase.
Wang CS; Weiser D; Alaupovic P; McConathy WJ
Arch Biochem Biophys; 1982 Mar; 214(1):26-34. PubMed ID: 7082001
[No Abstract] [Full Text] [Related]
14. Catabolism of very low density lipoproteins in experimental nephrosis.
Garber DW; Gottlieb BA; Marsh JB; Sparks CE
J Clin Invest; 1984 Oct; 74(4):1375-83. PubMed ID: 6480830
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the phospholipase activity of bovine milk lipoprotein lipase against rat plasma very low density and high density lipoprotein.
Eisenberg S; Schurr D; Goldman H; Olivecrona T
Biochim Biophys Acta; 1978 Dec; 531(3):344-51. PubMed ID: 216396
[TBL] [Abstract][Full Text] [Related]
16. Proteinuria and plasma compositional changes contribute to defective lipoprotein catabolism in the nephrotic syndrome by separate mechanisms.
Shearer GC; Kaysen GA
Am J Kidney Dis; 2001 Jan; 37(1 Suppl 2):S119-22. PubMed ID: 11158876
[TBL] [Abstract][Full Text] [Related]
17. Secretion of lipoproteins, apolipoprotein A-I and apolipoprotein E by isolated and perfused liver of rat with experimental nephrotic syndrome.
Calandra S; Gherardi E; Fainaru M; Guaitani A; Bartosek I
Biochim Biophys Acta; 1981 Aug; 665(2):331-8. PubMed ID: 6793079
[TBL] [Abstract][Full Text] [Related]
18. In vitro catabolism of human very low density lipoproteins: fate of apoproteins B and C.
Catapano AL; Capurso A; Kinnunen PK
Artery; 1981; 9(2):87-95. PubMed ID: 7295047
[TBL] [Abstract][Full Text] [Related]
19. [Lipoproteins, apolipoproteins, lipoprotein lipase, hepatic triglyceride lipase and lecithin cholesterol acyltransferase in patients with nephrotic syndrome].
Breier C; Lisch HJ; Drexel H; Braunsteiner H
Schweiz Med Wochenschr; 1983 Jun; 113(25):909-13. PubMed ID: 6612272
[TBL] [Abstract][Full Text] [Related]
20. Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism. Studies in normal and lipoprotein lipase-inhibited monkeys.
Goldberg IJ; Blaner WS; Vanni TM; Moukides M; Ramakrishnan R
J Clin Invest; 1990 Aug; 86(2):463-73. PubMed ID: 2117022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
